DePuy Synthes Accelerates Commitment to Digital Surgery in 2020

DePuy Synthes reported 4Q19 orthopedic revenue of USD $2,275 million, +0.6% vs. 4Q18, with full year 2019 revenue of $8,839 million, -0.5% vs. 2018. Company management noted positive momentum in orthopedics and overall franchise improvement compared to 2018. DePuy Synthes’ parent company, Johnson & Johnson, has strengthened its...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0